Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pet-ct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06204237
What this trial is testing

Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

Who this might be right for
Peripheral Arterial Occlusive DiseaseCritical Limb Ischemia
Aplagon Oy 10
Early research (Phase 1)Ended earlyNCT00584753
What this trial is testing

Molecular Imaging of Breast Cancer With Breast PET/CT

Who this might be right for
Breast Cancer
University of California, Davis 4
Not applicableUnknownNCT03134261
What this trial is testing

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic to Bone
Herlev Hospital 300
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Not applicableEnded earlyNCT05948137
What this trial is testing

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
Asan Medical Center 32
Not applicableStudy completedNCT04867603
What this trial is testing

Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions

Who this might be right for
Prostate Cancer
Norbert Avril, M.D. 16
Not applicableUnknownNCT03144622
What this trial is testing

18F-FSPG PET/CT Imaging in Patients With Cancers

Who this might be right for
Pulmonary CancerBreast NeoplasmsAbdominal Cancer
National Taiwan University Hospital 120
Not applicableApproved For MarketingNCT04334837
What this trial is testing

Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs)

Who this might be right for
Neuroendocrine Tumors
Curium US LLC
Not applicableStudy completedNCT06655545
What this trial is testing

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Fudan University 473
Not applicableStudy completedNCT07712172
What this trial is testing

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

Who this might be right for
Granulomatosis With Polyangiitis (Wegener's)
Post Graduate Institute of Medical Education and Research, Chandigarh 31
Not applicableStudy completedNCT04276272
What this trial is testing

D4 Choline Breast PET/CT

Who this might be right for
HER2-negative Breast CancerER Positive Breast CancerMetastatic Breast Cancer
Imperial College London 6
Not applicableUnknownNCT04214353
What this trial is testing

PSMA-PET Imaging Before and After ADT in Advanced SDC Patients

Who this might be right for
Salivary Gland CancerSalivary Duct Carcinoma
Radboud University Medical Center 14
Not applicableUnknownNCT03568799
What this trial is testing

4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Who this might be right for
Lung CancerSolitary Pulmonary NoduleCigarette Smoking Behavior
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05004285
What this trial is testing

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

Who this might be right for
High Risk Prostate Carcinoma
FutureChem 398
Not applicableStudy completedNCT01110174
What this trial is testing

Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms

Who this might be right for
Breast Cancer
University of California, Davis 8
Testing effectiveness (Phase 2)UnknownNCT03511768
What this trial is testing

18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine Neoplasm
Xiangya Hospital of Central South University 65
Not applicableStudy completedNCT02186678
What this trial is testing

Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation

Who this might be right for
ParagangliomasPheochromocytomas
Assistance Publique Hopitaux De Marseille 30
Not applicableLooking for participantsNCT07568613
What this trial is testing

Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 50
Testing effectiveness (Phase 2)Ended earlyNCT05009979
What this trial is testing

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute (NCI) 8
Not applicableUnknownNCT03051542
What this trial is testing

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Peking University Cancer Hospital & Institute 60
Next Page